Skip to main content
. 2022 Dec 6;11(23):e026388. doi: 10.1161/JAHA.121.026388

Table 3.

ROC Curves for Different Outcomes in Patients With AF and Cancer

Area under the curve (95% CI)
Variable Any bleeding Major bleeding ICH GB
HAS‐BLED score (continuous) 0.809 (0.808–0.810) 0.774 (0.772–0.776) 0.744 (0.740–0.748) 0.752 (0.749–0.755)
HAS‐BLED score ≥3 0.753 (0.751–0.754) 0.716 (0.714–0.718) 0.698 (0.694–0.702) 0.702 (0.699–0.704)
ATRIA score (continuous) 0.768 (0.766–0.769) 0.777 (0.774–0.779) 0.635 (0.629–0.641) 0.728 (0.725–0.731)
ATRIA score ≥5 0.678 (0.676–0.680) 0.700 (0.698–0.702) 0.563 (0.557–0.568) 0.662 (0.659–0.665)
ORBIT score (continuous) 0.918 (0.917–0.918) 0.870 (0.869–0.871) 0.742 (0.738–0.745) 0.825 (0.822–0.827)
ORBIT score ≥4 0.813 (0.811–0.814) 0.805 (0.804–0.807) 0.641 (0.635–0.646) 0.756 (0.753–0.758)

AF indicates atrial fibrillation; ATRIA, anemia, severe renal disease (eg, dialysis), age ≥75 years, prior bleeding, and hypertension; GB, gastrointestinal bleeding; HAS‐BLED, uncontrolled hypertension (systolic blood pressure >160 mm Hg), abnormal kidney (dialysis or transplant)/liver function (ie, cirrhosis), previous stroke, bleeding history or predisposition, elderly age (≥65 years), and drug (antiplatelet, nonsteroidal anti‐inflammatory drugs)/alcohol abuse; ICH, intracranial hemorrhage; ORBIT, older age ≥75 years, anemia, bleeding history, chronic kidney disease, and treatment with antiplatelet drugs; and ROC, receiver operating characteristic.